Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor

Case report OA: closed CC0 ⤵ 26 in-corpus citations
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper describes a case of persistent bilateral ureteral obstruction in a patient with endometriosis that continued despite treatment with an aromatase inhibitor.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To present a case demonstrating lack of efficacy of an aromatase inhibitor in treating ureteral endometriosis. DESIGN: Case report. SETTING: A tertiary-care hospital. PATIENT(S): A 47-year-old woman with severe ureteral endometriosis. INTERVENTION(S): Anastrozole 1 mg daily for 15 months. MAIN OUTCOME MEASURE(S): Renal function. RESULT(S): Despite medical management with anastrozole, our patient continued to have worsening renal function and subsequently required surgical intervention. CONCLUSION(S): Anastrozole was ineffective at preventing deterioration of renal function in this patient.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aromatase Inhibitors Endometriosis Nitriles Triazoles Ureteral Diseases Ureteral Obstruction Anastrozole Anastrozole Aromatase Inhibitors Aromatase Inhibitors Disease Progression Disease Progression Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (22)

Cited by (27)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:05:28.665087+00:00
unpaywall
last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0 · commercial use OK